Ryman Healthcare ltd [RYM.NZX] has had a good year results wise, with a 2010 half year profit up 25% on the comparable 2009 period. It has a long history of uninterrupted increasing profits and dividends.
While this success was reflected in the RYM stock price pre the 2008 stockmarket crash, post crash the stock reached as low as $1.12 at the beginning of 2009 on fears the property sector which had also crashed was going to impact on RYM - that was not to be. Since then the stock has pretty much risen unabated on a series of good profit results.
Yesterday the RYM stock price hit a 4 year intraday high of $2.57 and finished trading at $2.51 and is around 20c off its all time highs. The stock has put on nearly 10% in value since the end of March/ beginning of April and nearly 5% in just the last week.
Just to warn punters that the share price is at near high historical levels and while a positive 2011 Full Year profit out in May is probably the impetus for the rise, investors should be cautious at this fully priced company. While the historical growth levels may continue in the future, as they have for a decade or more and the share price may take a ride with it, it is worth backing off a bit if you already have your eyes on buying this company for the long term and buying on any weakness the share price may have.
Having said that results usually do the talking to the market and this could be the middle of a rise in share price that reflects the long term potential of this star NZX company.
Buy on weakness for excellent long-term gains.
Share Price Alert
Charlies Group Ltd
Fletcher Building Ltd 2
Contact Energy Ltd
Steel & Tube Ltd
Telecom New Zealand Ltd
New Zealand Stock Exchange Ltd
Mainfreight Ltd 2
The Warehouse Group Ltd
Pumpkin Patch Ltd
Hallenstein Glasson Holdings Ltd 2
Fletcher Building Ltd
Restaurant Brands Ltd
Goodman Fielder Ltd
Pumpkin Patch Ltd
Hallenstein Glasson Holdings Ltd
NZ Refining Ltd
Ryman Healthcare @ Share Investor
Ryman Healthcare Ltd: 2011 Half Year Profit Review
Gordon Macleod on Ryman Healthcare's Australian Expansion
Share Investor Q & A: Ryman Healthcare's CFO Gordon MacLeod
Ryman Healthcare: Interview sneak peak
Ryman Healthcare Ltd: Australian Expansion Needs Care
Share Investor Q & A: Reader Questions to Ryman CFO Gordon Macleod
Long Term View: Ryman Healthcare Ltd
Stock of the Week: Ryman Healthcare Ltd
Why did you buy that stock? [Ryman Healthcare]
Long VS Short: Ryman Healthcare Ltd
Time for retirement?
Discuss RYM @ Share Investor Forum
Download RYM Company Reports
Allan Hubbard: Man Out of Time - By Virginia Green
c Share Investor 2011
MYEFO shows cost of disputes with ATO at $5.1b - Sydney Morning Herald - Sydney Morning Herald *MYEFO shows cost of disputes with ATO at $5.1b* *Sydney Morning Herald* The value of tax disputes, including court cases between taxp...
12 hours ago